Показано 0 из 0
Дата |
---|
09.02.2024 |
08.02.2024 |
07.02.2024 |
06.02.2024 |
05.02.2024 |
02.02.2024 |
01.02.2024 |
31.01.2024 |
30.01.2024 |
29.01.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
28.92
|
28.99
|
28.74
|
28.74
|
28.74
|
28.74
|
|
|
|
|
28.93
|
29.01
|
27.21
|
27.21
|
29.00
|
28.95
|
|
|
72 700.70
|
7.00
|
27.44
|
27.49
|
27.22
|
27.22
|
27.22
|
27.22
|
|
|
|
|
27.39
|
27.46
|
27.04
|
27.04
|
27.04
|
27.04
|
|
|
|
|
27.27
|
27.34
|
26.91
|
26.91
|
26.91
|
26.91
|
|
|
|
|
27.09
|
27.16
|
26.81
|
26.81
|
26.81
|
26.81
|
|
|
|
|
26.97
|
27.04
|
26.91
|
26.65
|
26.91
|
26.65
|
|
|
21 320.00
|
2.00
|
27.15
|
27.22
|
26.97
|
26.97
|
26.97
|
26.97
|
|
|
|
|
27.09
|
27.16
|
27.05
|
27.05
|
27.05
|
27.05
|
|
|
|
|
27.10
|
27.17
|
27.03
|
27.03
|
27.36
|
27.36
|
|
|
1 284.22
|
4.00
|
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.